CONSUN PHARMAC.GR.HD -10

F:C1P Germany Drug Manufacturers - Specialty & Generic
Market Cap
$1.59 Billion
€1.55 Billion EUR
Market Cap Rank
#7876 Global
#837 in Germany
Share Price
€1.84
Change (1 day)
+1.10%
52-Week Range
€0.88 - €2.18
All Time High
€2.18
About

Consun Pharmaceutical Group Limited researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. It operates in two segments, Consun Pharmaceutical and Yulin Pharmaceutical. The company offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles for proteinuria; TCM to treat diabetic kidney… Read more

Market Cap & Net Worth: CONSUN PHARMAC.GR.HD -10 (C1P)

CONSUN PHARMAC.GR.HD -10 (F:C1P) has a market capitalization of $1.59 Billion (€1.55 Billion) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #7876 globally and #837 in its home market, demonstrating a -2.13% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying CONSUN PHARMAC.GR.HD -10's stock price €1.84 by its total outstanding shares 841141938 (841.14 Million).

CONSUN PHARMAC.GR.HD -10 Market Cap History: 2015 to 2026

CONSUN PHARMAC.GR.HD -10's market capitalization history from 2015 to 2026. Data shows growth from $1.38 Million to $1.59 Billion (99.22% CAGR).

CONSUN PHARMAC.GR.HD -10 Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how CONSUN PHARMAC.GR.HD -10's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:
  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
No financial ratio data available

Competitor Companies of C1P by Market Capitalization

Companies near CONSUN PHARMAC.GR.HD -10 in the global market cap rankings as of March 19, 2026.

Key companies related to CONSUN PHARMAC.GR.HD -10 by market ranking:

  • Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
  • Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
  • Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
  • Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).

Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#422 Zoetis Inc NYSE:ZTS $51.61 Billion $117.35
#432 Haleon plc NYSE:HLN $49.87 Billion $10.31
#452 Takeda Pharmaceutical Co. Ltd. PINK:TKPHF $47.47 Billion $30.07
#719 Jiangsu Hengrui Medicine Co Ltd SHG:600276 $28.19 Billion CN¥55.11

CONSUN PHARMAC.GR.HD -10 Historical Marketcap From 2015 to 2026

Between 2015 and today, CONSUN PHARMAC.GR.HD -10's market cap moved from $1.38 Million to $ 1.59 Billion, with a yearly change of 99.22%.

Year Market Cap Change (%)
2026 €1.59 Billion +12.20%
2025 €1.42 Billion +59.22%
2024 €889.31 Million +402.44%
2023 €177.00 Million +224.37%
2022 €54.57 Million +74.59%
2021 €31.26 Million +325.88%
2020 €7.34 Million +6.25%
2019 €6.91 Million +110.53%
2018 €3.28 Million -26.92%
2017 €4.49 Million +205.88%
2016 €1.47 Million +6.25%
2015 €1.38 Million --

End of Day Market Cap According to Different Sources

On Mar 19th, 2026 the market cap of CONSUN PHARMAC.GR.HD -10 was reported to be:

Source Market Cap
Yahoo Finance $1.59 Billion USD
MoneyControl $1.59 Billion USD
MarketWatch $1.59 Billion USD
marketcap.company $1.59 Billion USD
Reuters $1.59 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.